Clinical Trial Update: A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy [Phase 1]

View source ↗

Summary

A completed Phase 1 trial evaluating the effect of vemurafenib on the pharmacokinetics of phenprocoumon in patients with BRAFV600 mutation-positive metastatic m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Melanoma

Drugs mentioned

• Phenprocoumon (phenprocoumon)
• Vemurafenib (vemurafenib)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma, Neoplasms | Phase 1 | Status: COMPLETED